Patent Expiry – July 2020
The following list relates to patents, of the more commonly used brands, that are expected to expire.
Expiry dates may be extended by the drug companies.
Generic Name | Anticipated Patent Expiry | Brand |
Aliskiren tablets | Apr 2020 | Rasilez |
Rotigotine patch | Feb 2021 | Neupro |
Tapentadol tablets | Feb 2021 | Palexia |
Prucalopride tablets | May 2021 | Resolor |
Beclometasone + Formoterol inhaler | Jul 2021 | Fostair |
Varenicline tablets | Sep 2021 | Champix |
Amlodipine + Valsartan tablets | Dec 2021 | Exforge |
Exenatide injection (Byetta® only) | Nov 2021 | Byetta |